The connections between C75 and obesity drug-target pathways.

@article{Kuhajda2005TheCB,
  title={The connections between C75 and obesity drug-target pathways.},
  author={Francis P. Kuhajda and Leslie E. Landree and Gabriele V. Ronnett},
  journal={Trends in pharmacological sciences},
  year={2005},
  volume={26 11},
  pages={541-4}
}
Obesity and its attendant disorders, such as Type II diabetes, have reached epidemic proportions in the USA, and their prevalence is increasing globally. C75 is a small-molecule inhibitor of fatty acid synthase (FAS) and a stimulator of carnitine palmitoyl 1 activity, which causes profound weight loss in mice. Although C75 is not a compound that is destined for human drug development, it has provided two potential pathways to target in obesity therapy: fatty acid synthesis and fatty acid… CONTINUE READING
14 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…